missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Ulixertinib hydrochloride, MedChemExpress
Description
Ulixertinib hydrochloride (BVD-523 hydrochloride) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib hydrochloride inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line.
Specifications
Specifications
| Chemical Name or Material | Ulixertinib hydrochloride |
| CAS | 1956366-10-1 |
| Color | White |
| Purity Grade Notes | Research |
| Molecular Formula | C21H23Cl3N4O2 |
| Quantity | 10 mg |
| Synonym | BVD-523 hydrochlorideVRT752271 hydrochloride |
| Solubility Information | DMSO : 100 mg/mL (212.86 mM; Need ultrasonic) ∣H2O : 0.1 mg/mL (0.21 mM; ultrasonic and warming and heat to 80°C) |
| SMILES | O=C(C1=CC(C2=CC(NC(C)C)=NC=C2Cl)=CN1)N[C@@H](C3=CC=CC(Cl)=C3)CO.[H]Cl |
| Molecular Weight (g/mol) | 469.79 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?